Agilent product profile
Automated sample prep improves consistency and boosts productivity.
The new Agilent 7696A Sample Prep WorkBench reduces the time, cost, and tedium of manual sample preparation for GC or LC applications—dilutions, additions, heating/cooling, mixing, extraction, dispensing, and other operations. A simple, reliable productivity tool and a valuable addition to any busy lab, the standalone system improves the precision and reproducibility of every analysis, while freeing scientists up to focus on more challenging tasks.
Shortens prep time for virtually any analytical technique.
Versatile enough to accommodate specialized analytical techniques used in the pharmaceutical, petrochemical, food safety, consumer products, forensics, and environmental industries, the 7696A WorkBench has an extensive repertoire of capabilities; for example:
To learn more about the Agilent 7696A Sample Prep WorkBench, download the brochure at www.agilent.com/chem/workbench.
The Complexity of Oligonucleotide Separations
January 9th 2025Peter Pellegrinelli, Applications Specialist at Advanced Materials Technology (AMT) explains the complexity of oligonucleotide separations due to the unique chemical properties of these molecules. Issues such as varying length, sequence complexity, and hydrophilic-hydrophobic characteristics make efficient separations difficult. Separation scientists are addressing these challenges by modifying mobile phase compositions, using varying ion-pairing reagents, and exploring alternative separation modes like HILIC and ion-exchange chromatography. Due to these complexities, AMT has introduced the HALO® OLIGO column, which offers high-resolution, fast separations through its innovative Fused-Core® technology and high pH stability. Alongside explaining the new column, Peter looks to the future of these separations and what is next to come.
Metabolomics Analysis of Low Birth-Weight Infants Using UHPLC-MS/MS Following Lipid Emulsion
January 10th 2025A recent study aimed to directly compare the changes in serum metabolites among very low birth-rate (VLBW) infants following the administration of the soybean oil-based lipid emulsion and soybean oil, medium-chain triglycerides, olive oil, and fish oil (SMOF) lipid emulsion using untargeted metabolomics techniques.
Analyzing New Drug Modalities: An ISC 2024 Interview with Kelly Zhang
January 10th 2025At ISC 2024 in Liverpool, United Kingdom, LCGC International interviewed Kelly Zhang of Genentech about her work analyzing new drug modalities, such as mRNA, oligonucleotides, peptides, and cell and gene therapies.